GlassScriptPhysician profile
Leonel Alejandro Borjon
NPI 1528418647
$3,809.17
in general payments reported to CMS, 2019-2025
18 companies · $729 in 2025
The $729 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $257 · 2022: $534 · 2023: $1,278 · 2024: $1,012 · 2025: $729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,018.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,126.42 | 2021-2025 | Wavewriter Alpha Prime 16, Infinion 16 |
| Abbvie INC. | $728.41 | 2021-2025 | |
| Abbott Laboratories | $455.07 | 2023-2024 | Proclaim, Octrode |
| Medtronic, INC. | $452.17 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim |
| Spr Therapeutics, INC | $335.07 | 2022-2025 | Sprint Pns System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $173.87 | 2021-2024 | Relistor |
| Ibsa Pharma INC. | $138.53 | 2023-2025 | Licart, Tirosint, Flector |
| Pfizer INC. | $118.20 | 2023-2025 | |
| Redhill Biopharma INC. | $42.75 | 2023 | Movantik |
| Curonix LLC | $40.37 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Forte Bio-Pharma LLC | $37.34 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Axsome Therapeutics, INC. | $30.18 | 2025 | Symbravo |
| Vertos Medical, INC. | $26.05 | 2022 | |
| Collegium Pharmaceutical, INC. | $24.17 | 2024 | Belbuca |
| Tonix Medicines, INC. | $23.76 | 2025 | Tonmya |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impel Pharmaceuticals INC. | $22.98 | 2022 | |
| Almatica Pharma LLC | $18.85 | 2021 | |
| Amgen INC. | $14.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonel Borjon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.